|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Aegerion Pharmaceuticals, Inc. (AEGR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
31,480,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.97 - $1.97 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sumeray Mark |
Chief Medical Officer |
|
2014-01-16 |
4 |
AS |
$58.59 |
$117,269 |
D/D |
(2,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2014-01-16 |
4 |
OE |
$13.01 |
$26,020 |
D/D |
2,000 |
2,000 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2014-01-02 |
4 |
AS |
$70.22 |
$70,934 |
D/D |
(1,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2014-01-02 |
4 |
OE |
$13.01 |
$13,010 |
D/D |
1,000 |
1,000 |
|
- |
|
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2014-01-02 |
4 |
AS |
$70.65 |
$159,998 |
D/D |
(2,250) |
0 |
|
- |
|
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2014-01-02 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-12-16 |
4 |
AS |
$66.23 |
$132,687 |
D/D |
(2,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-12-16 |
4 |
OE |
$13.01 |
$26,020 |
D/D |
2,000 |
2,000 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,380 |
0 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-12-04 |
4 |
OE |
$1.54 |
$6,745 |
D/D |
4,380 |
4,380 |
|
- |
|
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2013-12-02 |
4 |
AS |
$70.10 |
$158,423 |
D/D |
(2,250) |
0 |
|
- |
|
Fraser Craig |
Pres., US/Int. Comm. & Manuf. |
|
2013-12-02 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-12-02 |
4 |
AS |
$70.23 |
$211,267 |
D/D |
(3,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-12-02 |
4 |
OE |
$13.01 |
$39,030 |
D/D |
3,000 |
3,000 |
|
- |
|
Fitzpatrick Mark J. |
Chief Financial Officer |
|
2013-11-18 |
5 |
GA |
$0.00 |
$0 |
I/I |
100 |
100 |
|
- |
|
Fitzpatrick Mark J. |
Chief Financial Officer |
|
2013-11-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
100 |
5,750 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-11-15 |
4 |
AS |
$74.93 |
$152,182 |
D/D |
(2,000) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-11-15 |
4 |
OE |
$13.01 |
$26,020 |
D/D |
2,000 |
2,000 |
|
- |
|
Fitzpatrick Mark J. |
Chief Financial Officer |
|
2013-11-11 |
4 |
OE |
$17.64 |
$182,574 |
D/D |
10,350 |
5,850 |
|
- |
|
Fitzpatrick Mark J. |
Chief Financial Officer |
|
2013-11-11 |
4 |
AS |
$73.01 |
$592,829 |
D/D |
(7,500) |
3,000 |
|
- |
|
Beer Marc D |
Chief Executive Officer |
|
2013-11-05 |
4 |
OE |
$1.54 |
$60,060 |
D/D |
39,000 |
234,726 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-11-01 |
4 |
AS |
$82.76 |
$291,481 |
D/D |
(3,500) |
0 |
|
- |
|
Sumeray Mark |
Chief Medical Officer |
|
2013-11-01 |
4 |
OE |
$13.01 |
$45,535 |
D/D |
3,500 |
3,500 |
|
- |
|
Carter Martha J |
Chief Regulatory Officer & SVP |
|
2013-11-01 |
4 |
AS |
$82.81 |
$414,051 |
D/D |
(5,000) |
1,500 |
|
- |
|
Carter Martha J |
Chief Regulatory Officer & SVP |
|
2013-11-01 |
4 |
OE |
$14.84 |
$74,200 |
D/D |
5,000 |
6,500 |
|
- |
|
251 Records found
|
|
Page 3 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|